Coronavirus Update: Spooked By America’s COVID-19 Vaccine Skepticism, FDA Promises Not To Lower Standards
Plus: Inovio Unveils Phase I Data, Reaction To Remdesivir Price
• By Scrip Team
An anti-vax campaigner in Huntington Beach, California, 24 April 2020. There are fears that even when a vaccine is approved, low uptake could limit its benefits.
Keep up with the top pharma business news of the week. On the go.
